Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma

5 Apr 2018

Abstract excerpt

Diffuse intrinsic pontine glioma (DIPG) is a universally fatal childhood cancer of the brain. Despite the introduction of conventional chemotherapy and radiotherapy, improvements in survival have been marginal and long-term survivorship is uncommon. Thus, new targets for therapeutics are critically needed. Early phase clinical trials exploring molecularly-targeted therapies against the epidermal growth factor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Toxin Mechanisms and Immunotoxins
Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29621254
DOI: 10.1371/journal.pone.0193565

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine gliomaPMID 29621254Read ↗

Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient PrognosisSemantic proximity Read ↗

Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme.Semantic proximity Read ↗

Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma.Semantic proximity Read ↗

Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.Semantic proximity Read ↗

Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma.Semantic proximity Read ↗

Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer.Semantic proximity Read ↗

Commentary: IL-4 and IL-13 receptors and signaling.Semantic proximity Read ↗

Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine gliomaSemantic proximity Read ↗

Polymorphisms in IL-4/IL-13 pathway genes and glioma risk: an updated meta-analysis.Semantic proximity Read ↗

Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2.Semantic proximity Read ↗

IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomasSemantic proximity Read ↗

A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.